These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9453349)
1. Oxytocin pathways mediate the cardiovascular and behavioral responses to substance P in the rat brain. Maier T; Dai WJ; Csikós T; Jirikowski GF; Unger T; Culman J Hypertension; 1998 Jan; 31(1 Pt 2):480-6. PubMed ID: 9453349 [TBL] [Abstract][Full Text] [Related]
2. C-FOS expression in the rat brain in response to substance P and neurokinin B. Spitznagel H; Baulmann J; Blume A; Unger T; Culman J Brain Res; 2001 Oct; 916(1-2):11-21. PubMed ID: 11597586 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists. Picard P; Regoli D; Couture R Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304 [TBL] [Abstract][Full Text] [Related]
4. Substance P induces a cardiovascular defense reaction in the rat: pharmacological characterization. Unger T; Carolus S; Demmert G; Ganten D; Lang RE; Maser-Gluth C; Steinberg H; Veelken R Circ Res; 1988 Oct; 63(4):812-20. PubMed ID: 2458861 [TBL] [Abstract][Full Text] [Related]
5. Identification of the central tachykinin receptor subclass involved in substance P-induced cardiovascular and behavioral responses in conscious rats. Itoi K; Tschöpe C; Jost N; Culman J; Lebrun C; Stauss B; Unger T Eur J Pharmacol; 1992 Sep; 219(3):435-44. PubMed ID: 1385176 [TBL] [Abstract][Full Text] [Related]
6. Tachykinin receptor inhibition and c-Fos expression in the rat brain following formalin-induced pain. Baulmann J; Spitznagel H; Herdegen T; Unger T; Culman J Neuroscience; 2000; 95(3):813-20. PubMed ID: 10670449 [TBL] [Abstract][Full Text] [Related]
7. Inhibition by morphine of the cardiovascular and behavioral responses evoked by centrally administered substance P in conscious rats. Itoi K; Jost N; Tschöpe C; Culman J; Badoer E; Unger T Neuropharmacology; 1994 Feb; 33(2):181-7. PubMed ID: 7518572 [TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing factor induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in rats. Diamant M; Kashtanov SI; Fodor M; de Wied D Neuroendocrinology; 1992 Nov; 56(5):750-60. PubMed ID: 1488107 [TBL] [Abstract][Full Text] [Related]
9. Distribution of Fos-like immunoreactivity in guinea-pig brain following administration of the neurokinin-1 receptor agonist, [SAR9,MET(O2)11]substance P. Yip J; Chahl LA Neuroscience; 1999; 94(2):663-73. PubMed ID: 10579226 [TBL] [Abstract][Full Text] [Related]
10. Regional haemodynamic effects of noradrenaline injected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats: possible mechanisms of action. Bachelard H; Harland D; Gardiner SM; Kemp PA; Bennett T Neuroscience; 1992; 47(4):941-57. PubMed ID: 1579218 [TBL] [Abstract][Full Text] [Related]
11. In vivo characterization of tachykinin receptors responsible for the central cardiovascular effects of substance P and neurokinin A. Culman J; Tschöpe C; Picard P; Prat A; Regoli D; Couture R; Unger T Regul Pept; 1993 Jul; 46(1-2):364-6. PubMed ID: 7692538 [No Abstract] [Full Text] [Related]
12. Localization of the substance P-induced cardiovascular responses in the rat hypothalamus. Itoi K; Jost N; Badoer E; Tschöpe C; Culman J; Unger T Brain Res; 1991 Aug; 558(1):123-6. PubMed ID: 1718566 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Schaffhauser AO; Stricker-Krongrad A; Brunner L; Cumin F; Gerald C; Whitebread S; Criscione L; Hofbauer KG Diabetes; 1997 Nov; 46(11):1792-8. PubMed ID: 9356028 [TBL] [Abstract][Full Text] [Related]
14. Substance P and neurokinin A induced desensitization to cardiovascular and behavioral effects: evidence for the involvement of different tachykinin receptors. Culman J; Tschöpe C; Jost N; Itoi K; Unger T Brain Res; 1993 Oct; 625(1):75-83. PubMed ID: 7694777 [TBL] [Abstract][Full Text] [Related]
15. Intracerebroventricular responses to neuropeptide gamma in the conscious rat: characterization of its receptor with selective antagonists. Picard P; Couture R Br J Pharmacol; 1996 Jan; 117(2):241-9. PubMed ID: 8789375 [TBL] [Abstract][Full Text] [Related]
16. Renal vasodilatation after central administration of galanin. Gardiner SM; Compton AM; Bennett T Brain Res; 1988 Aug; 458(1):176-9. PubMed ID: 2463042 [TBL] [Abstract][Full Text] [Related]
17. Role of NK-1 receptor in central cardiovascular regulation in rats: studies on a novel non-peptide antagonist, CP-96,345, of substance P NK-1 receptor. Saigo A; Takano Y; Saito R; Nakayama Y; Honda K; Kamiya H Regul Pept; 1993 Jul; 46(1-2):293-6. PubMed ID: 7692520 [No Abstract] [Full Text] [Related]
18. Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat. Tschöpe C; Picard P; Culman J; Prat A; Itoi K; Regoli D; Unger T; Couture R Br J Pharmacol; 1992 Nov; 107(3):750-5. PubMed ID: 1335337 [TBL] [Abstract][Full Text] [Related]
19. Central cardiovascular and behavioral effects of carboxy- and amino-terminal fragments of substance P in conscious rats. Tschöpe C; Jost N; Unger T; Culman J Brain Res; 1995 Aug; 690(1):15-24. PubMed ID: 7496802 [TBL] [Abstract][Full Text] [Related]
20. Enhanced pressor responses to ICV vasopressin after pretreatment with oxytocin. Poulin P; Komulainen A; Takahashi Y; Pittman QJ Am J Physiol; 1994 Feb; 266(2 Pt 2):R592-8. PubMed ID: 8141420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]